Psilocybin

In a recent conversation on The Joe Rogan Experience, Elon Musk and Joe Rogan delivered a sharp critique of the pharmaceutical industry, bashing its history of prioritizing profit over public safety. Their discussion not only touched on well-known scandals like OxyContin and Vioxx but also ventured...

A new study published in AJOB Neuroscience reveals that most Americans are supportive of psilocybin use, a psychedelic compound derived from "magic mushrooms," in supervised, licensed settings. As PsyPost reported, this approval, spanning across political lines, underscores public openness to the...

Between 1957 and 1967, Argentina experienced a brief yet profound intersection of psychoanalysis and psychedelics, with thousands of therapeutic sessions conducted through the controlled use of LSD and other substances. These treatments, led by pioneering psychotherapists like Dr. Alberto Fontana...

As psilocybin slowly gains acceptance as a potential mental health treatment, websites claiming to sell magic mushrooms are multiplying online, operating in a gray area of legality. As DoubleBlind reported, while psilocybin remains a Schedule I substance in the U.S., these sites are capitalizing on...

The debate over the effects of different psilocybin mushroom strains has long divided growers and users. Psilocybe cubensis varieties like Golden Teacher, B+ and Z-strain are often believed to have distinct psychedelic effects, leading to endless online discussions and confusion for newcomers...

Army combat vet CJ LoConte credits psilocybin, the active ingredient in “magic mushrooms,” with transforming his life. Once hospitalized for suicidal ideation after battling mental health issues, LoConte says psychedelics saved him by offering an alternative when traditional therapies...

A new study conducted by Monash University researchers offers promising insights into how psilocybin, a compound found in magic mushrooms, may help treat major depression. As Medicalxpress reported, in a groundbreaking experiment, rats treated with psilocybin demonstrated increased optimism and...

Researchers from Emory University, the University of Wisconsin-Madison and UC-Berkeley have identified a significant opportunity for psilocybin-assisted therapy in the U.S. mental healthcare landscape. As U.S. News reported, if approved by the FDA, psilocybin could be used to treat depression, with...

Missouri is dedicating $5 million from its opioid settlement fund to research the potential of psilocybin in treating opioid use disorder. As Marijuana Moment reported, this funding initiative follows the passage of HB 2010, a state spending bill, and aims to curb overdose deaths by exploring...

Michigan could soon become the latest state to allow the legal use of psychedelic mushrooms for individuals with post traumatic stress disorder (PTSD). As Marijuana Moment reported, a new bill introduced by State Rep. Mike McFall (D) proposes legalizing up to two ounces of psilocybin mushrooms for...

A groundbreaking study from New York’s Columbia University suggests that psilocybin, the psychoactive compound in magic mushrooms may offer relief to individuals suffering from body dysmorphic disorder (BDD). The research, published in Psychedelics, explored the effects of psilocybin on brain...

The Minnesota Psychedelic Medicine Task Force (PMTF) is making strides toward finalizing a set of recommendations on how the state might regulate psychedelic substances, including psilocybin, MDMA and LSD. According to Marijuana Moment, the group has already approved the creation of a state-...

The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable emphasis on boosting the supply of certain psychedelics for research purposes. As Marijuana Moment reported, among the substances marked for increased production...

Researchers found that psilocybin, the active compound in magic mushrooms, performs just as well as the commonly prescribed antidepressant escitalopram (Lexapro) in reducing depression symptoms, with additional benefits for patients' overall well-being. The findings, published on September 21 in...

Psyence Biomedical Ltd. (NASDAQ:PBM), a biotechnology company focused on creating natural psychedelic-based solutions to address mental health challenges, has issued an update to shareholders, highlighting significant recent developments and upcoming milestones. The company has initiated a Phase...